These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9533092)

  • 1. Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones.
    Medders WM; Wooley RE; Gibbs PS; Shotts EB; Brown J
    Avian Dis; 1998; 42(1):146-53. PubMed ID: 9533092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
    Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
    Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline.
    Wang C; Ewing M; Aarabi SY
    Avian Dis; 2001; 45(2):456-60. PubMed ID: 11417828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibility to quinolones of Salmonella isolated from men and animals].
    Avril JL; Couete I; Travert MF; Autuly F; Plessis P
    Pathol Biol (Paris); 1995 Apr; 43(4):270-3. PubMed ID: 7567113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
    Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
    Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone resistance in veterinary isolates of Salmonella.
    Griggs DJ; Hall MC; Jin YF; Piddock LJ
    J Antimicrob Chemother; 1994 Jun; 33(6):1173-89. PubMed ID: 7928811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
    Brothers AM; Gibbs PS; Wooley RE
    Vet Ther; 2002; 3(4):493-500. PubMed ID: 12584687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression.
    Randall LP; Eaves DJ; Cooles SW; Ricci V; Buckley A; Woodward MJ; Piddock LJ
    J Antimicrob Chemother; 2005 Aug; 56(2):297-306. PubMed ID: 15956100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005.
    Akiba M; Nakaoka Y; Kida M; Ishioka Y; Sameshima T; Yoshii N; Nakazawa M; Uchida I; Terakado N
    J Antimicrob Chemother; 2007 Dec; 60(6):1235-42. PubMed ID: 17956907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
    Delsol AA; Woodward MJ; Roe JM
    J Antimicrob Chemother; 2004 Feb; 53(2):396-8. PubMed ID: 14711838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
    Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
    Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.
    Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1998 Sep; 32(1):55-64. PubMed ID: 9791759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.
    Malorny B; Schroeter A; Helmuth R
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2278-82. PubMed ID: 10471579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of fluoroquinolone-resistant coliforms in poultry litter.
    Hofacre CL; de Cotret AR; Maurer JJ; Garritty A; Thayer SG
    Avian Dis; 2000; 44(4):963-7. PubMed ID: 11195655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathotypes of avian Escherichia coli as related to tsh-, pap-, pil-, and iuc-DNA sequences, and antibiotic sensitivity of isolates from internal tissues and the cloacae of broilers.
    Ngeleka M; Brereton L; Brown G; Fairbrother JM
    Avian Dis; 2002; 46(1):143-52. PubMed ID: 11922326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance and minimum inhibitory concentrations of bacteria isolated from bustards in the United Arab Emirates.
    Bailey TA; Silvanose C; Wernery U; Samour JH; Naldo J
    Avian Dis; 1998; 42(4):690-7. PubMed ID: 9876837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
    Albayrak F; Cokca F; Erdem B; Aysev AD
    Int J Antimicrob Agents; 2004 Apr; 23(4):332-6. PubMed ID: 15081080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.